Notice of Annual Results for the 12 Months Ended 31 December 2023 |

11 Mar 2024

Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, expects to announce its annual results for the 12 months ended 31 December 2023 on Monday, 25 March 2024.

A Company presentation for analysts and investors will take place on the day at 8.30am (UK) via an in-person meeting and a live webcast and conference call.

To attend the in-person presentation, please contact:

To view the live webcast, please register in advance at:

The conference call dial-in is available using the below details:

Phone number: +44 (0) 33 0551 0200

Participant access quote: Impact Healthcare – Full Year Results

If you would like to ask your questions verbally, please use the dial in number. Alternatively, you can type questions into the webcast question box.

The presentation will also be accessible on demand later in the day on the Company’s website:


Impact Health Partners LLP  via Maitland/AMO
Andrew Cowley
Mahesh Patel
David Yaldron

Jefferies  International Limited
Tom Yeadon,
Ollie Nott,
Tel: +4420 7029 8000

Winterflood Securities Limited
Neil Langford,
Joe Winkley,
Tel: +4420 3100 0000

H/Advisors Maitland (Communications Adviser)
James Benjamin,
Rachel Cohen
Tel: +44 7747 113 930

The Company’s LEI is 213800AX3FHPMJL4IJ53.

Further information on Impact Healthcare REIT is available at

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.
The Company’s dividend policy is to maintain a progressive dividend that is covered by adjusted earnings.
On this basis, the target total dividend for the year ending 31 December 2024 is 6.95 pence per share*, a 0.18 pence increase over the 6.77 pence in dividends paid or declared per ordinary share for the year ended 31 December 2023.
The Group’s Ordinary Shares trade on the main market of the London Stock Exchange, premium segment. The Company is a constituent of the FTSE EPRA/NAREIT index.
*     This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company’s expected or actual results.